NuCana (NCNA) Other Working Capital Changes (2019 - 2024)
NuCana (NCNA) reported Other Working Capital Changes of $254133.4 for Q4 2024, up 204.04% sequentially from -$244268.4 in Q3 2024.
NuCana (NCNA) Other Working Capital Changes (2019 - 2024) Analysis & Trends
NuCana (NCNA) has 6 years of Other Working Capital Changes data on file, last reported at $254133.4 in Q4 2024.
- For the quarter ending Q4 2024, Other Working Capital Changes changed N/A year-over-year to $254133.4; the trailing twelve-month figure through Dec 2025 stood at $9864.9 (up 4.26% YoY), and the FY2025 full-year result was -$52740.4, down 512.59% from the prior year.
- Other Working Capital Changes advanced to $254133.4 in Q4 2024, from -$244268.4 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $254133.4 in Q4 2024 to a low of -$3.8 million in Q3 2023.
- A 5-year average of -$362199.7 and a median of -$97713.4 in 2020 frame the typical range for Other Working Capital Changes.
- Across the five-year window, Other Working Capital Changes slumped 1334.72% in 2023 and soared 106.12% in 2024, its largest moves.
- Tracing NCNA's Other Working Capital Changes over 5 years: stood at -$97713.4 in 2020, then declined by 2.09% to -$99752.8 in 2021, then gained by 7.84% to -$91929.9 in 2022, then plunged by 4033.64% to -$3.8 million in 2023, then soared by 106.69% to $254133.4 in 2024.
- Business Quant data shows NCNA's Other Working Capital Changes at $254133.4 in Q4 2024, -$244268.4 in Q3 2024, and $80782.1 in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Alnylam Pharmaceuticals | 35.71 Bn | 32.70 Bn | 959.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 254,133.36 |
| Dec 31, 2024 | 254,133.36 |
| Dec 31, 2024 | 254,133.36 |
| Sep 30, 2024 | -244,268.43 |
| Sep 30, 2024 | -244,268.43 |
| Sep 30, 2024 | -244,268.43 |
| Jun 30, 2024 | 80,782.13 |
| Jun 30, 2024 | 80,782.13 |
| Jun 30, 2024 | 80,782.13 |
| Mar 31, 2024 | -81,185.16 |
| Mar 31, 2024 | -81,185.16 |
| Mar 31, 2024 | -81,185.16 |
| Sep 30, 2023 | -3.80 Mn |
| Sep 30, 2023 | -3.80 Mn |
| Sep 30, 2023 | -3.80 Mn |
| Jun 30, 2023 | -1.32 Mn |
| Jun 30, 2023 | -1.32 Mn |
| Jun 30, 2023 | -1.32 Mn |
| Mar 31, 2023 | -66,853.02 |
| Mar 31, 2023 | -66,853.02 |